What Node Labs does

Node Labs is a privately held plant tissue culture micropropagation company headquartered in San Francisco, California, founded in 2018. Micropropagation is a laboratory technique in which small explants of plant tissue are cultured under sterile conditions to produce large volumes of genetically uniform clones, a method commonly applied to scale consistent, disease-free planting stock for high-value crops such as cannabis/hemp and other specialty ornamentals. The firm's website surfaces structured navigation referencing a "Genetic Library" and "Strain Detail" page, indicating that the company maintains a proprietary catalog of characterized plant genetics and offers clone-lines as a core product. The company is founder-led: Daniel Adler-Golden is identified as Founder and CEO.

The business model is B2B plant-input supply: Node Labs produces clonal tissue-cultured plantlets and likely sells them (directly or under contract) to cultivators, with revenue mechanics inferred — but not disclosed — to be unit-priced plantlet sales or propagation service contracts. Public pricing, customer logos, distribution channels, and segment mix are not stated in the source material, and the website pages reviewed are predominantly structural/navigational, offering minimal commercial detail. Headcount is reported as 11-50 employees, and the firm operates as a for-profit, private company with no public ticker.

Capital structure and strategic activity are limited in disclosure: a single funding round of $350,000 on 2018-05-21 with Big Rock as an investor is the only financing event on record, no parent, subsidiaries, M&A, partnerships, awards, patents, or regulatory actions are documented, and no management team beyond the founder-CEO is named. There are no certifications, integrations, AI/ML modalities, app presence, or API products disclosed. Operating geographies are unspecified beyond the San Francisco headquarters, and the website was recently re-launched in an SEO-optimized form (described as "Nodelabs Remastered"), suggesting light ongoing commercial activity rather than aggressive expansion. Overall the evidence base supports characterization as an early-stage, founder-operated tissue culture lab with a proprietary genetic catalog and minimal external capital; deeper commercial intelligence was not available in the provided data.

Name

Node Labs

Website

https://nodelabsca.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Node Labs is a San Francisco-based plant tissue culture micropropagation company that produces genetically uniform clones from a proprietary genetic catalog, serving cultivators of cannabis and other specialty crops via B2B plantlet supply.

Ownership category

akta.pro rank

Product category

Plant Tissue Culture

NAICS

Soil Preparation, Planting, and Cultivating (115112)

SIC

Agricultural Services (700)

akta.pro primary industry

Tissue Culture & Micropropagation (Planting Material) (AFAGAIAN)

Keywords

• Plant tissue culture
• Micropropagation services
• Clonal propagation
• Genetic library
• Plant biotechnology

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Core offering

Node Labs is a plant tissue culture micropropagation company that produces clonal, disease-free plant specimens through laboratory tissue culture. The firm maintains a Genetic Library of strains and offers a documented propagation process, supplying uniform plant material to commercial buyers.

Differentiator

Problem solved

Functional benefit

Products and services

• Plant Tissue Culture Micropropagation Production of clonal, disease-free plant specimens through laboratory tissue culture methods, supplied to commercial growers and cultivators who need genetically uniform starting material.
• Genetic Library Maintained catalog of plant strains accessible via the company's Genetic Library page, with individual Strain Detail entries describing each available cultivar for buyer reference.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Direct peers

• Conception Nurseries: Conception Nurseries operates tissue-culture cannabis propagation facilities supplying clean, verified clones to licensed growers — a near-twin business model to Node Labs' plant tissue culture micropropagation focus.
• Front Range Biosciences: Front Range Biosciences runs commercial plant tissue culture micropropagation for cannabis and hemp, producing clean, disease-free clones from a genetics library — the same core offering as Node Labs and the most directly comparable scaled US peer.
• Segra International: Segra is a tissue-culture micropropagation specialist serving cannabis cultivators with clean-stock clones from a centralized genetics library, making it a direct competitor in the same niche market as Node Labs.
• Dark Heart Nursery: Dark Heart is a major US supplier of cannabis clones and plantlets to licensed growers, with its own genetics catalog — comparable to Node Labs as a competing supplier of rooted planting material to the same customer base.
• Phylos Bioscience: Phylos maintains a large cannabis genetics catalog and has worked on clean propagation and breeding programs, competing for the same genetics-plus-propagation customer base that Node Labs addresses.
• OGEN (Oregon Genetics): OGEN runs cannabis tissue culture micropropagation and clean-stock production out of Oregon, overlapping directly with Node Labs on both production method (micropropagation) and target product (clean cannabis clones).

Emerging players

• Meristematics: Meristematics is a Canadian cannabis tissue-culture startup focused on micropropagation of clean clones — an emerging direct competitor with similar technique and target customers, though at an earlier stage than the largest US peers.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Node Labs